In this CME accredited online course exclusively for SIOP members, you will hear from international experts about state-of-the-art targeted therapies in pLGG going form molecular neuropathology to the various MAPK alterations and corresponding targeted treatment options (approved, approval pending, and in clinical development). Functional outcome with targeted therapy is another topic and it is important to address the chronic nature of the disease.
Learning Objectives
- Learn about the treatment for children with Paediatric low-grade gliomas (pLGGs)
- Review the management options available for Paediatric low-grade gliomas (pLGGs)
- Manage side effects and toxicities
- Identify interprofessional team strategies for improving care coordination and communication to advance diagnosis and treatment of low-grade gliomas, and improve patient outcomes
Speakers
- Olaf Witt Hopp Children’s Cancer Center Heidelberg (Germany)
- Felix Sahm University Clinic Heidelberg (Germany) Prof
- Darren Hargrave University College London/Great Ormond Street Hospital (UK)
- Lindsay Kilburn Children’s National Hospital (USA)
- Karsten Nysom Copenhagen University Hospital Rigshospitalet (Denmark)
Supported by an unrestricted educational grant from IPSEN.
Approved Credit: 1 hour(s) CME
Access course here.
For technical issues, please contact our team at info@siop-online.org
